TYK76: Difference between revisions
Jump to navigation
Jump to search
m (1 revision imported) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
In reference to treating laryngospasm, what is the intravenous (IV) dose for succinylcholine? | In reference to treating laryngospasm, what is the intravenous (IV) dose for succinylcholine? | ||
| Line 11: | Line 10: | ||
D. 4 mg/kg | D. 4 mg/kg | ||
<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div> | |||
<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer"> | |||
<div class="mw-collapsible- | |||
==Answer== | ==Answer== | ||
The answer is A. | The answer is A. | ||
So before anyone gets too crazy about this, let me make a point. The intubating dose is still 1-2 mg/kg. However, more | So before anyone gets too crazy about this, let me make a point. The intubating dose is still 1-2 mg/kg. However, more recent studies have shown that the LARYNGOSPASM dosage is as low as 0.1 mg/kg IV. This provides many benefits such as shorter (if any) apnea time, less need for additional sedation or mechanical ventilation. The authors suggest that the lower dosage may not cause apnea but will relieve laryngospasm due to the sensitivity of the larynx to succinylcholine.<ref>Chung, D. C., and S. J. Rowbottom. "A very small dose of suxamethonium relieves laryngospasm." Anaesthesia 48.3 (1993): 229-230.[http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.1993.tb06908.x/abstract]</ref>==Notes== | ||
==Notes== | |||
<references /> | <references /> | ||
==Keywords== | ==Keywords== | ||
</div> | </div> | ||
---- | ---- | ||
---- | ---- | ||
Revision as of 23:23, 23 January 2022
In reference to treating laryngospasm, what is the intravenous (IV) dose for succinylcholine?
A. 0.1 mg/kg
B. 1 mg/kg
C. 3 mg/kg
D. 4 mg/kg
Click for Answer
Answer
The answer is A.
So before anyone gets too crazy about this, let me make a point. The intubating dose is still 1-2 mg/kg. However, more recent studies have shown that the LARYNGOSPASM dosage is as low as 0.1 mg/kg IV. This provides many benefits such as shorter (if any) apnea time, less need for additional sedation or mechanical ventilation. The authors suggest that the lower dosage may not cause apnea but will relieve laryngospasm due to the sensitivity of the larynx to succinylcholine.[1]==Notes==